Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Human trials inform device policy integration; leaves open optimal patient selection in registries.
Establishing a national health policy at a macro level involves the integration of a series of health initiatives across a spectrum of activities, including clinical care. Evaluation of the safety and efficacy of a new medical device ultimately evolves to testing in humans. The pathway to a formal prospective clinical trial includes a stepwise appreciation of pre-clinical data and detailed analysis of data obtained from preliminary registries, where information about appropriate patient selection and use of the device is obtained. Evaluation of procedural and follow-up efficacy and safety data in a preliminary series of cases, chosen to simulate published data, allows the design and conduct of clinical trials that are required to verify preliminary observations, closing the loop on one aspect of modifying health policy decisions.
No takes yet. Share an insight, caveat, or question.
Ricci et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: